Dr. Ebele Ola is the Vice-President of Clinical, Medical and Regulatory Affairs at Novo Nordisk Canada. She leads a team of Clinical, Medical and Regulatory Professionals dedicated to the conduct of clinical research in Canada, ensuring approval of innovative medicines and the unbiased dissemination of scientific data to health care professionals, to support improved patient outcomes. She is a member of the Novo Nordisk Canada Executive Team. Ebele has been with J&J in Canada since 2008. Prior to joining Johnson & Johnson, Ebele was Medical Director and Principal Investigator, overseeing a team of over 100 clinical research professionals in the conduct of Phase I to Phase III Clinical trials. During this period, the company grew by 50 percent and inpatient capacity increased four-fold. In 2016, Ebele was recognized as a Healthcare Businesswomen's Association Rising Star. She is passionate about Diversity, Equity, & Inclusion, and sponsored the Diverse Future Leaders Program in partnership with McMaster University over the last 3 years. She has also served as Executive Sponsor for the J&J Women's Leadership Initiative for the last 7 years. Ebele obtained her Medical Degree from the University of Toronto in Canada, followed by a residency in Family Medicine at Mount Sinai Hospital in Toronto and a Sports Medicine Fellowship. Outside of her professional life, she enjoys latin dancing and traveling to new destinations with her husband and daughter.